Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
A photon-counting CT system tracks individual photon interactions using a photon-counting detector (PCD). A spectral or energy-resolved CT is a technique in which the detector pixels of a PCD record an approximate energy spectrum by keeping track of the deposited energy in each interaction. Energy-integrating detectors (EIDs) are used in typical CT scanners to register the overall energy from a large number of photons as well as electronic noise deposited in a pixel over a specified period of time. Photon-counting CT has the potential to enhance the scientific capabilities of traditional CT, such as the viewing of minute features of organ structures, more precise material density size and improved tissue characterization. With the rising prevalence of a variety of chronic diseases there is a growing demand for photon counting-CT.
The photon-counting CT market is propelled by rising global demand for early identification of chronic diseases. A rise in cancer prevalence will result from changes in lifestyle habits such as tobacco usage and smoking, as well as growing levels of air pollution. A photon-counting CT scanner is used to diagnose diseases accurately. Significant advances in imaging technology are likely to boost the photon-counting CT market forward.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the photon counting CT market. In addition, complete analysis of changes on the photon counting CT market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
United States photon counting CT market includes different market segment like product type, application and end user.
By product type photon counting CT market is segmented into single channel counting system and multichannel counting system. Single channel counting system is expected to grow in the forecasted period due to its wide applications in biomedical and chemical research has focused on optical analysis to better understand biological processes. A range of analytical issues, including as sample throughput, precision, and analysis time, are addressed by multi-channel devices. Multi-channel counting system can also help with the analysis of quick transient signals produced by gas or liquid chromatography, flow injection, capillary electrophoresis, electro thermal evaporation, and laser ablation. In the anticipated term, the widespread use of multichannel counting systems is expected to boost the segments expansion.
The photon counting CT market is primarily used in cardiology, cancer, and neurology, among other fields. Cardiology is predicted to develop in the country due to rising demand for early identification of heart problems, growing senior population and rising healthcare expenditure are expected factors to increase in the market growth during the forecast period. As this technology has the potential to be a significant step forward for CT imaging, establishing a new standard of treatment and subsequently improving clinical outcomes for millions of patients in the country.
The photon counting CT market has different end user like hospitals, specialty clinics, imaging and analysis centers. The hospitals segment is predicted to grow in the forecast period due to the rise in prevalence of cancer patients, sedentary lifestyle and also the urge of early diagnosis of cardiac disorders is resulting in the expansion of hospitals segment in the country. Also, the specialty clinics are likely to grow in the forecast period.
The key players in Photon Counting CT Market are Picoquant, Becker & Hickl Gmbh, Hidex Oy, Id, Quantique (Idq), Photek, Thorlabs Inc., Ge Healthcare among others.
November 2020: GE Healthcare (NYSE:GE) said today that it has acquired Prismatic Sensors, a Swedish startup with deep silicon detector technology for photon-counting computed tomography (PCCT). photon counting CT technology, according to GE Healthcare, could expand the clinical capabilities of traditional CT — providing diagnostic benefits in clinical areas including oncology, cardiology and neurology. PCCT can enable the visualization of minute organ structure details, improved tissue characterization and more accurate material density measurement (or quantification). Plus, the radiation dose is lower.
September 2020: PicoQuant’s rapidFLIM HiRes combines ultra-fast FLIM imaging with outstanding 10 ps time resolution. Users can now visualize dynamic processes in cells or tissues with unprecedented acquisition speed and time resolution. Imaging dynamic processes in tissues or cells require methods that are fast, reliable, and quantitative. Scientists and engineers at PicoQuant have developed rapidFLIM HiRes which enables imaging samples at up to 15 frames per second with a time resolution of 10 ps using Fluorescence Lifetime Imaging (FLIM).
The report analyses the photon counting CT market based on different market segment like product type, application and end user. By product type photon counting CT market is segmented into single channel counting system and multichannel counting system. The single channel counting system has wide applications in research including biology, chemistry, medicine, and space technology due to which it is expected to propel the growth of the market multi-channel devices are used to address a variety of analytical challenges, including sample throughput, precision, and analysis time. The photon counting CT market finds its major application in cardiology oncology, neurology and others. Due to the increasing demand for early diagnosis of cardiac disorders the cardiology segment is expected to grow in the forecast period. The hospitals segment is expected to grow in the forecasted period due to the increase in prevalence of cancer patients due to sedentary lifestyle and the urge of early diagnosis of cardiac disorders. The United States is expected to gain major market share in the forecast period due to rising prevalence of cancer and increase in the number of geriatric populations in the country.
